Economic evaluations of genomic testing may have misleading conclusions

Oncotype DX, a gene profiling test for women with early-stage breast cancer, may not be as effective a tool as commonly thought, according to a new study.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news